pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 3·1 min read
save

Medical schools debate AI scribes as teaching tools versus learning crutches

Aug 3, 2026·read at STAT ↗Neutral

Hospitals have rapidly adopted AI-powered note-taking tools, saying they reduce physician burnout and boost revenue.

Medical schools, however, are cautious. While they want graduates to be comfortable with AI scribes, educators fear that relying on the technology may prevent students from fully engaging in clinical reasoning.

Yale's associate dean of educational technology, Jaideep Talwalkar, emphasizes that writing notes forces trainees to think through diagnoses repeatedly, a skill that could be eroded if AI does the work.

As a result, many training programs are limiting trainee access to AI scribes until more evidence clarifies their impact on learning.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Are AI scribes useful tools in medical education, or a crutch that imperils learning?”

read at STAT ↗
475 words · retrieved Aug 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2LILLY
drugs
Rare Disease2insulin
topics
Rare Disease2ALSCardiology

related stories

  • Aug 18Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemiaBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • 1d agoSionna says good-bye to 46% of staffers, including execBioSpace
  • 1d agoNovartis halts TREM2 targeting ALS program in 4th trial stumble in a monthBioSpace
  • 3d agoNovo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrandBioSpace